Viral bronchiolitis is the most common cause of admission to hospital for infants in high-
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …

Bronchiolitis is an acute respiratory illness that is the leading cause of hospitalization in
young children. This document aims to update the consensus document published in 2014 …

This guideline is a revision of the clinical practice guideline,“Diagnosis and Management of
Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline …

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract
disease, especially in young children. Despite its global impact on healthcare, related to its …

A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was
facilitated by the European Respiratory Society (ERS) and the International Society for …

In global terms, respiratory viral infection is a major cause of morbidity and mortality. Infancy,
in particular, is a time of increased disease susceptibility and severity. Early-life viral …

The global burden of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI)
in young children is high. The RSV prevention strategies approved in 2023 will be essential …

Respiratory syncytial virus (RSV) is a major worldwide cause of morbidity and mortality in
children under five years of age. Evidence-based management guidelines suggest that …

Respiratory syncytial virus (RSV) is responsible for a large burden of disease globally and
can present as a variety of clinical syndromes in children of all ages. Bronchiolitis in infants …

Background Previous systematic reviews have not shown clear benefit of glucocorticoids for
acute viral bronchiolitis, but their use remains considerable. Recent large trials add …